Mode
Text Size
Log in / Sign up
N/A N=121 Randomized Single-blind Treatment

A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression

Depression

Enrolled (actual)
121
Serious AEs
3.3%
Results posted
Jun 2017
Primary outcome: Primary: Beck Hopelessness Scale (BHS) — 4.888889; 4.428571 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Behavioral Activation (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
National Center for Telehealth and Technology
Primary completion
Jan 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Beck Hopelessness Scale (BHS)
5.214286; 5.527778
SECONDARY
Adverse Events
6; 2
SECONDARY
Beck Depression Inventory -II (BDI-II)
14.7619; 15
SECONDARY
Adverse Events
6; 2
SECONDARY
Adverse Events
6; 2
SECONDARY
Adverse Events
6; 2
SECONDARY
Adverse Events
6; 2
SECONDARY
Adverse Events
6; 2
SECONDARY
Adverse Events
6; 2
SECONDARY
Adverse Events
6; 2
SECONDARY
Adverse Events
6; 2
SECONDARY
Beck Depression Inventory -II (BDI-II)
14.7619; 15
SECONDARY
Beck Depression Inventory -II (BDI-II)
14.7619; 15
SECONDARY
Beck Depression Inventory -II (BDI-II)
14.7619; 15
SECONDARY
Beck Hopelessness Scale (BHS)
5.214286; 5.527778
SECONDARY
Beck Hopelessness Scale (BHS)
5.214286; 5.527778
SECONDARY
Beck Hopelessness Scale (BHS)
5.214286; 5.527778

Summary

This study will evaluate the effectiveness of a web-based behavioral activation(BA) treatment for depression by comparing it to in-person BA treatment in Soldiers and Veterans with Major and Minor Depressive Disorder. We will test the hypothesis that 8 sessions of in-home BA delivered via a webcam will be as safe and effective in reducing symptoms of hopelessness and depression as in-person BA treatment for depression.

Eligibility Criteria

Inclusion Criteria

  • Current Major Depressive or Minor Depressive Disorder
  • High-speed internet/network access at home (384kbs minimum)
  • Informed consent
  • Fluent in the English language

Exclusion Criteria

  • Currently undergoing psychotherapy for depression
  • less than 18 or greater than 65 year of age
  • Active psychotic symptoms/disorders as determined by the SCID for DSM-IV
  • Dysthymic Disorder
  • Current suicidal ideation with intent or recent (within six months) history of a suicide attempt
  • History of Organic Mental Disorder
  • Current substance dependence as determined by the SCID (lifetime substance dependence or substance abuse will not be excluded)
  • History of violence or poor impulse control causing potential risk to staff or others
  • Significant ongoing stressors that require urgent crisis intervention
  • Having a living arrangement that will not permit the use of a private space to participate in the study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01599585). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search